Clinical trial NCT00080119 - References

Tuberculosis — Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV

Citation(s)

•   Chintu C, Mwaba P
  Tuberculosis in children with human immunodeficiency virus infection. Int J Tuberc Lung Dis. 2005 May;9(5):477-84. Review.
•   Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C
  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003 May 12;163(9):1009-21. Review.
•   Cotton M, Kim S, Rabie H, Coetzee J, Nachman S
  A window into a public program for prevention of mother to child transmission of HIV: evidence from a prospective clinical trial. South Afr J HIV Med. 2009 Jan 1;10(4):16-19.
•   Cotton MF, Schaaf HS, Lottering G, Weber HL, Coetzee J, Nachman S; PACTG 1041 Team
  Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis. 2008 Feb;12(2):225-7.
•   de Jong BC, Israelski DM, Corbett EL, Small PM
  Clinical management of tuberculosis in the context of HIV infection. Annu Rev Med. 2004;55:283-301. Review.
•   Toossi Z
  Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease. J Infect Dis. 2003 Oct 15;188(8):1146-55. Epub 2003 Sep 30. Review.

A Randomized, Double Blind, Placebo Controlled Trial to Determine the Efficacy of Isoniazid (INH) in Preventing Tuberculosis Disease and Latent Tuberculosis Infection Among Infants With Perinatal Exposure to HIV

Details for clinical trial NCT00080119